Medindia

X

Reportlinker Adds Disease and Therapy Review: Hepatitis B

Friday, March 19, 2010 General News J E 4
Advertisement


NEW YORK, March 18 Reportlinker.com announces that a new market research report is available in its catalogue:

Disease and Therapy Review: Hepatitis B

http://www.reportlinker.com/p0183446/Disease-and-Therapy-Review-Hepatitis-B.html

Abstract

The Hepatitis B Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the hepatitis B market, as well as sales of leading drugs and therapies and future therapies are provided.

Additional Details

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

Overview

General considerations

INCIDENCE, prevalence and mortality

Incidence Table (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, Latin America, Worldwide)

Prevalence Table (US, Canada, Mexico, UK, Italy, Spain, Japan, China, India Worldwide)

Mortality Table (US, China, Europe, Africa, the Americas, Eastern Mediterranean, Southeast Asia, Western Pacific Worldwide)

diagnosis

Markers

Common serologic patterns

treatment

dosing

treatment costs

market size

future therapies

comments

references/resources

To order this report:

Therapy Industry: Disease and Therapy Review: Hepatitis B

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Arizona Kids 'Kick Butts' on March 24
S
Victims of Contaminated Meat Call on USDA to Addre...